Anemia Complicating PregnancyHB PhNCT07800611
Pharmacist Led Intervention in the Management of Anemia Among Pregnant Woman
A study testing Pharmacist-led counseling on anemia management in people with Anemia Complicating Pregnancy, run by Hamdard University at 1 site in Pakistan.
Trial summary
Anemia is a major public health problem among pregnant women, particularly in low- and middle-income countries. It is characterized by a reduction in hemoglobin concentration or the oxygen-carrying capacity of the blood, which may be insufficient to meet the physiological needs of the body. Read more about this study
- Who is it for?
- Any age, women only
- Conditions the study is for
- Anemia Complicating Pregnancy
- What is being tested?
- Pharmacist-led counseling on anemia management
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 sitePakistan
- Study dates
- 10 Sep 2026to 15 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Pregnant woman
- Hb <11g/dl
- Having Punjab domicile-
Who cannot join
- Patients with co-morbidities
- Patients with Hb >11g/dl
- Outside the Punjab domicile
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site
DHQ Chakwal
Islamabad, Islamabad, 45570
Maria Amin, Pharm D, 00923490526766, mattiullah@hotmail.com
About this study
Official title: Pharmacist Led Intervention in the Management of Anemia Among Pregnant woman-a Randomized Controlled Trial
Anemia is a major public health problem among pregnant women, particularly in low- and middle-income countries. It is characterized by a reduction in hemoglobin concentration or the oxygen-carrying capacity of the blood, which may be insufficient to meet the physiological needs of the body. Maternal anemia is associated with an increased risk of adverse maternal and fetal outcomes.
Despite the high prevalence of anemia among pregnant women, poor medication adherence and inadequate understanding of prescribed therapy may limit treatment effectiveness. Pharmacists can play an important role in providing medication-related education, improving patients' understanding of their treatment, identifying barriers to adherence, and promoting appropriate medication use. However, evidence on pharmacist-led educational interventions to improve medication adherence and hemoglobin levels among anemic pregnant women in Pakistan remains limited.
Read more
Therefore, this randomized controlled trial will be conducted to evaluate the effect of a structured pharmacist-led educational intervention on medication adherence and hemoglobin levels among anemic pregnant women in District Chakwal, Punjab, Pakistan.
A total of 100 eligible pregnant women diagnosed with anemia will be recruited and randomly allocated into intervention and control groups. Participants in the intervention group will receive a structured pharmacist-led educational intervention in addition to routine care, while participants in the control group will receive routine antenatal care and standard anemia management.
Medication adherence and hemoglobin levels will be assessed at baseline and after the intervention. The study will determine whether pharmacist-led educational counseling improves medication adherence and hemoglobin levels compared with routine care.
Data will be analyzed using IBM SPSS Statistics version 26. A paired-sample t-test will be used to compare changes in continuous variables, particularly hemoglobin levels, between baseline and post-intervention assessments. McNemar's test will be used to assess changes in paired categorical variables, including medication adherence where appropriate. A p-value of <0.05 will be considered statistically significant.
- Conditions
- Anemia Complicating Pregnancy
- Being tested
- Pharmacist-led counseling on anemia management
- Keywords
- Anemia, Pharmacist, intervention
- Medical subject headings
- Anemia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pharmacist-led counseling on anemia managementOther
Also called Pharmacist-Led Anemia Counseling
Intervention Description: Patients will receive individualized pharmacist-led counseling regarding anemia management, medication adherence, appropriate use of prescribed medicines, dietary measures, and strategies to improve quality of life. Outcomes will be assessed before the intervention and at one-month follow-up.
Study Design: Single-arm, pre-post evaluation.
| Study group | Role | What they receive |
|---|---|---|
| Pre and post evaluation | Other | Pharmacist-Led Anemia Counseling: Patients will receive individualized pharmacist-led counseling regarding anemia management, medication adherence, appropriate use of prescribed medicines, dietary measures, and strategies to improve quality of life. Outcomes will be assessed before the intervention and at one-month follow-up. Study Design: Single-arm, pre-post evaluation. Receives: Other: Pharmacist-led counseling on anemia management |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in hemoglobin concentration
Description: Change in hemoglobin (Hb) concentration from baseline to one-month follow-up, measured in g/dL using a laboratory hemoglobin test.
Measured: Baseline and one month after the pharmacist-led counseling intervention.
Change in anemia severity
Description: Change in anemia severity from baseline to one-month follow-up, categorized according to the participant's measured hemoglobin concentration using the predefined diagnostic criteria for anemia.
Measured: Baseline and one month after the pharmacist-led counseling intervention.
Medication adherence
Description: Change in medication adherence from baseline to one-month follow-up, assessed using the [name of your actual validated adherence scale/questionnaire].
Measured: Time Frame: Baseline and one month after the intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Sep 2026
- Study start10 Sep 2026 (estimated)
- Primary completion15 Oct 2026 (estimated)
- Study completion15 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Anemia Complicating PregnancyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hamdard University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Muhammad Abubakar, Hamdard University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07800611
- Sponsor's protocol ID
- ERC-FoP-2023-007
- Acronym
- HB Ph
- Status last verified
- Aug 2026
- First submitted
- 18 Aug 2026
- Last updated
- 2 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Adje, D., et al. (2020). "Impact of pharmacists' health educational intervention on anemia in pregnancy in rural settings in Kano, Nigeria." Int. J. Pharm. Sci. Res 11: 2403-2410.
Study at a glance
From the registry record, last updated by the sponsor on 2 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pharmacist Led Intervention in the Management of Anemia Among Pregnant woman-a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07800611
- Acronym / sponsor ID
- HB Ph / ERC-FoP-2023-007
- Conditions
- Anemia Complicating Pregnancy
- Keywords
- Anemia, Pharmacist, intervention
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Hamdard UniversityUniversity, hospital or other
- Study start
- 10 Sep 2026 (estimated)
- Primary completion
- 15 Oct 2026 (estimated)
- Study completion
- 15 Nov 2026 (estimated)
- First posted
- 2 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Anemia is a major public health problem among pregnant women, particularly in low- and middle-income countries. It is characterized by a reduction in hemoglobin concentration or the oxygen-carrying capacity of the blood, which may be insufficient to meet the physiological needs of the body. Maternal anemia is associated with an increased risk of adverse maternal and fetal outcomes.
Despite the high prevalence of anemia among pregnant women, poor medication adherence and inadequate understanding of prescribed therapy may limit treatment effectiveness. Pharmacists can play an important role in providing medication-related education, improving patients' understanding of their treatment, identifying barriers to adherence, and promoting appropriate medication use. However, evidence on pharmacist-led educational interventions to improve medication adherence and hemoglobin levels among anemic pregnant women in Pakistan remains limited.
Therefore, this randomized controlled trial will be conducted to evaluate the effect of a structured pharmacist-led educational intervention on medication adherence and hemoglobin levels among anemic pregnant women in District Chakwal, Punjab, Pakistan.
A total of 100 eligible pregnant women diagnosed with anemia will be recruited and randomly allocated into intervention and control groups. Participants in the intervention group will receive a structured pharmacist-led educational intervention in addition to routine care, while participants in the control group will receive routine antenatal care and standard anemia management.
Medication adherence and hemoglobin levels will be assessed at baseline and after the intervention. The study will determine whether pharmacist-led educational counseling improves medication adherence and hemoglobin levels compared with routine care.
Data will be analyzed using IBM SPSS Statistics version 26. A paired-sample t-test will be used to compare changes in continuous variables, particularly hemoglobin levels, between baseline and post-intervention assessments. McNemar's test will be used to assess changes in paired categorical variables, including medication adherence where appropriate. A p-value of <0.05 will be considered statistically significant.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pre and post evaluation | Other | Other: Pharmacist-led counseling on anemia managementPharmacist-Led Anemia Counseling: Patients will receive individualized pharmacist-led counseling regarding anemia management, medication adherence, appropriate use of prescribed medicines, dietary measures, and strategies to improve quality of life. Outcomes will be assessed before the intervention and at one-month follow-up. Study Design: Single-arm, pre-post evaluation. |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- Pregnant woman
- Hb <11g/dl
- Having Punjab domicile-
Key exclusion criteria (3 listed)
- Patients with co-morbidities
- Patients with Hb >11g/dl
- Outside the Punjab domicile
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pharmacist-led counseling on anemia managementAlso: Pharmacist-Led Anemia CounselingIntervention Description: Patients will receive individualized pharmacist-led counseling regarding anemia management, medication adherence, appropriate use of prescribed medicines, dietary measures, and strategies to improve quality of life. Outcomes will be assessed before the intervention and at one-month follow-up. Study Design: Single-arm, pre-post evaluation. | Other | Pre and post evaluation |
Primary outcome
Change in hemoglobin concentration
Time frame: Baseline and one month after the pharmacist-led counseling intervention.
Description: Change in hemoglobin (Hb) concentration from baseline to one-month follow-up, measured in g/dL using a laboratory hemoglobin test.
Change in anemia severity
Time frame: Baseline and one month after the pharmacist-led counseling intervention.
Description: Change in anemia severity from baseline to one-month follow-up, categorized according to the participant's measured hemoglobin concentration using the predefined diagnostic criteria for anemia.
Medication adherence
Time frame: Time Frame: Baseline and one month after the intervention.
Description: Change in medication adherence from baseline to one-month follow-up, assessed using the [name of your actual validated adherence scale/questionnaire].
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Sep 2026.
- Results publicationAdje, D., et al. (2020). "Impact of pharmacists' health educational intervention on anemia in pregnancy in rural settings in Kano, Nigeria." Int. J. Pharm. Sci. Res 11: 2403-2410.
- Individual participant dataSharing planned: Undecided
Related trials for Anemia Complicating Pregnancy
Active, not recruitingPhase 2
Management of Iron Deficiency Anemia in Hemodialysis Patients
Iron Deficiency Anemia (IDA), ESRD (End Stage Renal Disease)
Active, not recruitingPhase 3
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Atypical Hemolytic Uremic Syndrome
RecruitingObservational study
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL)
Not yet recruitingPhase 1
Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease
Chronic Kidney Disease, Anemia
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Pharmacist-led counseling on anemia management in people with Anemia Complicating Pregnancy, run by Hamdard University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 2 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Muhammad Abubakar, PhD (00923237166544, mabubakar.pharmacist@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in hemoglobin concentration (time frame: Baseline and one month after the pharmacist-led counseling intervention.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07800611, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2026.